gvtcx

RSV 2024

UK Health Security Agency Published 27 Nov 2023 Contracts Finder

key details

Statusplanned
Category (CPV) 33651600 +1 more
Contract start1 Jul 2024
Contract end30 Jun 2028
Procedureopen
SME suitableNo
OCIDocds-b5fd17-598dc806-e973-4aeb-9562-692b5e6d1902

description

The provision of immunisation products indicated for the prevention or protection from Respiratory Syncytial Virus (RSV) lower respiratory tract disease

The contracting authority estimates their requirement for deliveries between 1 July 2024 to 30 June 2026 ('Initial Term') of the contract to be up to 1.6 million doses for Lot 1, up to 1.69 million doses for Lot 2, up to 1.45 million doses for Lot 3 or up to 4 million doses for Lot 4, with the option to extend for up to an additional 24 months.

notice history

1 notice published against this procurement.

PublishedTypeRegimeNotice
27 Nov 2023 Planning (planning) · bdda5b73-5ff0-49f9-83d4-7ac7cf0acf01-701877

more from UK Health Security Agency

all contracts from this buyer →

similar contracts awarded

Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.

source

Published on Contracts Finder. Contact details for named individuals are not reproduced on this site.